País: Israel
Idioma: inglés
Fuente: Ministry of Health
RIVAROXABAN
PROPHARM LTD
B01AF01
FILM COATED TABLETS
RIVAROXABAN 15 MG
PER OS
Not required
ADALVO LIMITED, MALTA
RIVAROXABAN
Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age≥75 years, diabetes mellitus, prior stroke or transient ischaemic attack. Treatment of deep vein thrombosis (DVT),and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.Paediatric populationTreatment of venous thromboembolism (VTE) and prevention of VTE recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment.
2023-12-20
PATIENT PACKAGE INSERT IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS (PREPARATIONS) – 1986 The medicine is dispensed with a doctor’s prescription only RIVAROXABAN PROPHARM 15 MG RIVAROXABAN PROPHARM 20 MG FILM-COATED TABLETS Each tablet contains: rivaroxaban 15 mg rivaroxaban 20 mg Inactive ingredients and allergens in the preparation: see section 6 “Further information” and section 2 under “Important information about some of the ingredients of the medicine”. READ THIS LEAFLET CAREFULLY IN ITS ENTIRETY BEFORE USING THE MEDICINE. This leaflet contains concise information about the medicine. If you have further questions, refer to your doctor or pharmacist. This medicine has been prescribed for the treatment of your ailment. Do not pass it on to others. It may harm them even if it seems to you that their ailment is similar. In addition to the leaflet, the Rivaroxaban Propharm is provided with a patient safety information card. This card contains important information that you must know and abide by before starting and during treatment with Rivaroxaban Propharm. Read the Patient Safety Information Card and the patient leaflet before starting to use the preparation. Keep the card and leaflet for further reading if necessary. 1. WHAT IS THE MEDICINE INTENDED FOR? Rivaroxaban Propharm is intended for adults with the following conditions: • to prevent blood clots in brain (stroke) and other blood vessels in the body in patients with an irregular heart rhythm called non-valvular atrial fibrillation and with one or more of the following risk factors: congestive heart failure, high blood pressure, age (75 or older), diabetes, prior stroke, or transient ischemic attack. • to treat blood clots in the veins of the legs (deep vein thrombosis) and in the blood vessels of the lungs (pulmonary embolism) and to prevent the recurrence of blood clots in the blood vessels of the legs and/or lungs. Rivaroxaban Propharm is intended for children and adolescents below the age of 18 who weigh between 30 kg to 50 kg: Leer el documento completo